Seghatchian, Jerard
308  Ergebnisse:
?
1

Editorial comments: Looking for some innovative diagnostic ..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  63 (2024)  3 - p. 103927 , 2024
 
?
2

Editorial comments: Two clinical viewpoints from Oslo:

Seghatchian, Jerard
Transfusion and Apheresis Science.  63 (2024)  4 - p. 103968 , 2024
 
?
4

Editorial commentary:

Seghatchian, Jerard
Transfusion and Apheresis Science.  63 (2024)  1 - p. 103850 , 2024
 
?
5

Spotlights on the trends in performance assessment of quali..:

Pereira, Paulo ; Seghatchian, Jerard
Transfusion and Apheresis Science.  63 (2024)  2 - p. 103887 , 2024
 
?
6

Editorial comment: Reflections on current position and futu..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  63 (2024)  5 - p. 103986 , 2024
 
?
7

An invite for evidence-based insights and expert viewpoints..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  4 - p. 103784 , 2023
 
?
8

Cryopreservation of apheresis platelets treated with ribofl..:

Kutac, Dominik ; Bohonek, Milos ; Landova, Ludmila...
Transfusion and Apheresis Science.  62 (2023)  2 - p. 103580 , 2023
 
?
9

Spotlight on SARS CoV-2 infection inducing autoimmunity, th..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  1 - p. 103626 , 2023
 
?
 
?
11

Editorial commentary – A snapshot on the role of newer tech..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  6 - p. 103826 , 2023
 
?
13

What's happening editorial commentary: Immunological impact..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  3 - p. 103720 , 2023
 
?
14

Spotlight on the impact of transfusion support, the detrime..:

Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  2 - p. 103684 , 2023
 
?
15

Autoimmune complications of COVID-19 and potential conseque..:

Amiral, Jean ; Seghatchian, Jerard
Transfusion and Apheresis Science.  62 (2023)  1 - p. 103625 , 2023
 
1-15